RCE recce pharmaceuticals ltd

Ann: Appendix 4E and Unaudited Preliminary Report, page-4

  1. 106 Posts.
    lightbulb Created with Sketch. 20
    How can Recce justify such significant increases in remuneration for its executives?

    Total remuneration up 73%

    Total employee benefits expense up 78%

    James and Michelle's base remuneration up over 60% each.

    Travel costs nearly $1 million yet Recce has focussed its trials etc in Australia.

    Current operations are now being funded via debt from Radium Capital.

    At 30 June 2023 the company had significant negative net assets, what a disaster.

    Financially, management appears to be out of their depth.

    Surely it is time for an experienced CEO to be appointed!!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.5¢
Change
-0.005(1.28%)
Mkt cap ! $111.3M
Open High Low Value Volume
38.5¢ 38.5¢ 37.0¢ $21.54K 57.86K

Buyers (Bids)

No. Vol. Price($)
1 3248 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 49884 1
View Market Depth
Last trade - 14.27pm 30/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.